12 Health Care Stocks Moving In Friday's Pre-Market Session

Loading...
Loading...

Gainers

  • Bullfrog AI Hldgs BFRG stock increased by 47.6% to $4.03 during Friday's pre-market session. The company's market cap stands at $22.7 million.
  • Rubius Therapeutics RUBY shares moved upwards by 31.71% to $0.15. The company's market cap stands at $13.5 million.
  • Ardelyx ARDX shares rose 17.3% to $3.39. The market value of their outstanding shares is at $673.1 million. The company's, Q4 earnings came out yesterday.
  • Akari Therapeutics AKTX shares rose 16.24% to $0.38. The market value of their outstanding shares is at $28.2 million.
  • Milestone Scientific MLSS shares rose 13.92% to $0.9. The company's market cap stands at $62.8 million.
  • Conformis CFMS stock increased by 10.46% to $1.9. The market value of their outstanding shares is at $14.2 million. As per the press release, Q4 earnings came out 2 days ago.

Losers

  • Praxis Precision Medicine PRAX shares decreased by 43.8% to $1.64 during Friday's pre-market session. The market value of their outstanding shares is at $85.9 million.
  • Cidara Therapeutics CDTX shares decreased by 16.58% to $1.51. The market value of their outstanding shares is at $108.1 million.
  • OncoSec Medical ONCS shares decreased by 15.17% to $2.35. The company's market cap stands at $6.9 million.
  • Biophytis BPTS stock decreased by 15.14% to $0.5. The market value of their outstanding shares is at $10.1 million.
  • Lucira Health LHDX stock decreased by 14.02% to $0.48. The market value of their outstanding shares is at $19.5 million.
  • Biomerica BMRA shares declined by 8.64% to $2.54. The company's market cap stands at $34.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...